Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Foghorn Therapeutics Inc (FHTX)

Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 251,652
  • Shares Outstanding, K 56,551
  • Annual Sales, $ 22,600 K
  • Annual Income, $ -86,620 K
  • EBIT $ -87 M
  • EBITDA $ -88 M
  • 60-Month Beta 3.04
  • Price/Sales 10.93
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 322.31% (-367.02%)
  • Historical Volatility 84.64%
  • IV Percentile 68%
  • IV Rank 26.91%
  • IV High 976.58% on 10/21/25
  • IV Low 81.47% on 08/18/25
  • Expected Move (DTE 8) 0.94 (20.87%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 317
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 2,047
  • Open Int (30-Day) 2,177
  • Expected Range 3.55 to 5.42

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.30
  • Number of Estimates 5
  • High Estimate -0.22
  • Low Estimate -0.34
  • Prior Year -0.30
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.22 +6.16%
on 11/14/25
5.68 -21.20%
on 11/17/25
+0.04 (+0.90%)
since 11/11/25
3-Month
3.27 +37.00%
on 11/04/25
5.68 -21.20%
on 11/17/25
-0.80 (-15.15%)
since 09/11/25
52-Week
2.94 +52.13%
on 04/03/25
6.79 -34.02%
on 07/28/25
-1.70 (-27.51%)
since 12/11/24

Most Recent Stories

More News
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference

CAMBRIDGE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases...

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update

Ongoing FHD-909 (LY4050784) Phase 1 dose escalation trial in SMARCA4 (BRG1)-mutated cancer remains on track with non-small cell lung cancer (NSCLC) as the primary target population  Selective CBP...

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases...

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs

- Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; potentially relevant in up to 5% of all solid tumors  ...

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit

CAMBRIDGE, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases...

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat...

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update

FHD-909 (LY4050784) Phase 1 dose escalation trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population, is enrolling well and remains on track ...

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update

FHTX : 4.48 (+0.67%)
Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference

FHTX : 4.48 (+0.67%)

Business Summary

Foghorn Therapeutics Inc. engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system. Foghorn Therapeutics Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 4.76
2nd Resistance Point 4.67
1st Resistance Point 4.58
Last Price 4.48
1st Support Level 4.40
2nd Support Level 4.31
3rd Support Level 4.22

See More

52-Week High 6.79
Fibonacci 61.8% 5.32
Fibonacci 50% 4.87
Last Price 4.48
Fibonacci 38.2% 4.41
52-Week Low 2.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar